MedTrace Logo

Establishment, Verification and Clinical Application of Chinese Version of Surgical Risk Assessment System

NCT05754268 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2023-03-07

No results posted yet for this study

Summary

The goal of this observational study is to establish and verify the Chinese version of surgical risk assessment system and explore its clinical application. The main questions it aims to answer are: The process of establishing a Chinese version of surgical risk assessment system; What is the accuracy of the system; How can the system be used in clinic; How does this system compare with other systems (such as NSQIP). Participants will comprehensively collect the general information, examination and pathological information of the patients, using machine learning and artificial intelligence methods for data processing. Finally, the Chinese version of the surgical risk assessment system will be established. After the system is established, investigators will evaluate the accuracy of the system and compare it with other related systems.

Conditions

  • Risk Assessment
  • Risk Factors
  • Machine Learning
  • Artificial Intelligence
  • Postoperative Complications
  • Operative Surgical Procedure

Interventions

PROCEDURE

Chinese version of the surgical risk assessment system

There is no need to interfere with the patient. Investigators can observe the outcome after using the system for evaluation.

Sponsors & Collaborators

  • luyun

    lead OTHER

Principal Investigators

  • Lu Yun, Doctor · The Affiliated Hospital of Qingdao University

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2024-08-31
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05754268 on ClinicalTrials.gov